secwatch.observer — SEC 8-K summary
======================================

Issuer:     Finch Therapeutics Group, Inc. (FNCHQ)
CIK:        0001733257
Form:       8-K
Filed at:   2024-05-24T23:59:59+00:00
Accession:  0001193125-24-146454
Event type: regulatory
Sentiment:  negative
Materiality: 0.90
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Finch Therapeutics receives Nasdaq delisting notice; trading suspended May 28
-----------------------------------------------------------------------------

- Nasdaq Listing Panel determined to delist Finch; company deemed a 'public shell' without an operating business.
- Trading of common stock suspended at opening on May 28, 2024; Nasdaq will file Form 25-NSE after 45 days.
- Common stock expected to trade on OTC market, but no assurance of prompt or continued trading.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1733257/000119312524146454/0001193125-24-146454-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1733257/000119312524146454/d818218d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-146454

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer